Trials / Completed
CompletedNCT00541437
Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
An Open-Label Study to Investigate the Efficacy and Safety of Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Genovate Biotechnology Co., Ltd., · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of type 2 diabetes patients switched from sulfonylurea co-administered with metformin to glyburide/metformin combination tablet. It is expected that safety and efficacy of GlucoMet® is not inferior to co-administration of sulfonylurea and metformin.
Conditions
Timeline
- Start date
- 2006-05-01
- Completion
- 2007-02-01
- First posted
- 2007-10-10
- Last updated
- 2007-10-10
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00541437. Inclusion in this directory is not an endorsement.